ACIU logo

AC Immune SA (ACIU) Company Overview

Profile

Full Name:

AC Immune SA

Sector:

Healthcare

Industry:

Biotechnology

Country:

Switzerland

IPO:

September 23, 2016

Indexes:

Not included

Website:

http://www.acimmune.com

Description:

AC Immune SA is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases, such as Alzheimer's. They use advanced technology to create treatments that target protein misfolding, aiming to improve patient outcomes and quality of life. Their research is driven by scientific expertise and collaboration.

Key Details

Price

$2.41

Market Cap

$238.45 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$16.48 M(+299.51% YoY)

Annual EPS

-$0.71(+20.03% YoY)

PE Ratio

-

Annual ROE

-32.34%

Annual Debt To Equity

0.00

Beta

1.15

Events Calendar

Earnings

Next earnings date:

Mar 13, 2025

Recent quarterly earnings:

Oct 24, 2024

Recent annual earnings:

Feb 6, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 15, 24 HC Wainwright & Co.
Buy
Nov 6, 24 HC Wainwright & Co.
Buy
Sep 18, 24 HC Wainwright & Co.
Buy
May 31, 24 BTIG
Buy
Mar 15, 24 HC Wainwright & Co.
Buy
Nov 13, 23 HC Wainwright & Co.
Buy
Aug 7, 23 HC Wainwright & Co.
Buy
Jun 28, 23 HC Wainwright & Co.
Buy
May 1, 23 HC Wainwright & Co.
Buy
Apr 19, 23 HC Wainwright & Co.
Buy

Screeners with ACIU included

Stocks with high beta
Biggest stock losers today
Stocks below SMA 200
Healthcare sector
All stocks
High Altman Z score stocks
NASDAQ Listed Companies
Companies with buyback
Biotechnology industry
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$2.41
ACIU price is $2.41

Price All-time High

$19.30
ACIU price is currently -87.51% below its historical high of $19.30

Price Analysts Target

-
ACIU price consensus analysts' forecast is unknown

Price Most Recent Change

-6.95%
ACIU price was down -6.95% on Mar 7, 2025

Price YTD Change

-10.74%
ACIU price is down -10.74% since January 1st

Price 3-Year Change

-32.11%
ACIU price is down -32.11% over the past 3 years

Market cap

Market Cap

$238.45 M
ACIU market capitalization is $238.45 million

Market Cap 3-Year Change

-19.54%
ACIU market capitalization is down -19.54% over the past 3 years

Market Cap All-time High

$1.08 B
ACIU market capitalization is currently -78.01% below its historical high of $1.08 billion

Market Cap Sector Rank

57.94%
ACIU market capitalization is higher than 57.94% of companies in Healthcare sector

Technical

Beta

1.15
ACIU beta is 1.15

200-day SMA

$3.28
ACIU price is currently -26.53% below its 200-day simple moving average

14-day RSI

39.38
ACIU 14-day relative strength index is 39.38

30-day Relative Volume

1.08
ACIU 30-day relative volume is 1.08

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$16.48 M
ACIU annual revenue is $16.48 million

Annual Revenue Analysts Estimate

$26.97 M
ACIU annual revenue is currently -38.88% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+299.51%
ACIU annual revenue is up +299.51% year-on-year

Annual Revenue Sector Rank

33.18%
ACIU annual revenue is higher than 33.18% of companies in Healthcare sector

Profit

Annual Gross Profit

-
ACIU annual gross profit value is unknown

Annual Gross Margin

-
ACIU annual gross profit margin value is unknown

Annual Operating Profit

-$59.72 M
ACIU annual operating income is -$59.72 million

Annual Operating Margin

-362.30%
ACIU annual operating profit margin is -362.30%

Annual Net Income

-$60.40 M
ACIU annual net profit is -$60.40 million

Annual Net Margin

-366.41%
ACIU annual net profit margin is -366.41%

EPS

Annual EPS

-$0.71
ACIU annual earnings per share is -$0.71

Annual EPS Analysts Estimate

-$0.54
ACIU annual earnings per share is currently +31.81% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+20.03%
ACIU annual earnings per share is up +20.03% year-on-year

Annual EPS Sector Rank

64.91%
ACIU annual earnings per share is higher than 64.91% of companies in Healthcare sector

ROA & ROE

Annual ROA

-28.88%
ACIU annual return on assets is -28.88%

Annual ROE

-32.34%
ACIU annual return on equity is -32.34%

EBIT & EBITDA

Annual EBIT

-$60.19 M
ACIU annual earnings before interest & taxes is -$60.19 million

Annual EBITDA

-$57.72 M
ACIU annual EBITDA is -$57.72 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ACIU price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ACIU price to earnings ratio is unknown

PB Ratio

PB Ratio

1.54
ACIU price to book ratio is 1.54

PB Ratio Sector Rank

52.64%
ACIU price to book ratio is higher than 52.64% of companies in Healthcare sector

PS Ratio

PS Ratio

5.08
ACIU price to sales ratio is 5.08

PS Ratio Sector Rank

63.89%
ACIU price to sales ratio is higher than 63.89% of companies in Healthcare sector

Enterprise value

Enterprise Value

$203.58 M
ACIU enterprise value is $203.58 million

Enterprise Value Sector Rank

57.34%
ACIU enterprise value is higher than 57.34% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.85
ACIU EV/EBITDA is -4.85

EV/EBITDA Sector Rank

21.98%
ACIU EV/EBITDA is higher than 21.98% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

9.22
ACIU annual current ratio is 9.22

Annual Quick Ratio

-
ACIU annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
ACIU annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-307.09
ACIU annual interest coverage ratio is -307.09

Risk & Stability

Piotroski F-Score

-
ACIU piotroski f-score value is unknown

Altman Z-Score

2.89
ACIU altman z-score is 2.89

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$217.65 M
ACIU annual total assets is $217.65 million

Annual Non Current Assets

$68.65 M
ACIU annual long term assets is $68.65 million

Annual Current Assets

$149.00 M
ACIU annual total current assets is $149.00 million

Annual Cash & Cash Equivalents

$93.45 M
ACIU annual cash & cash equivalents is $93.45 million

Equity

Annual Book Value

$191.25 M
ACIU annual book value is $191.25 million

Annual Working Capital

$132.84 M
ACIU annual working capital is $132.84 million

Liabilities

Annual Total Liabilities

$26.40 M
ACIU annual total liabilities is $26.40 million

Annual Total Long Term Liabilities

$10.23 M
ACIU annual total long term liabilities is $10.23 million

Annual Current Liabilities

$16.16 M
ACIU annual total current liabilities is $16.16 million

Annual Accounts Payable

$2.00 M
ACIU annual accounts payable is $2.00 million

Debt

Annual Total Debt

$4.16 M
ACIU annual total debt is $4.16 million

Annual Total Debt 1-Year Change

+37.81%
ACIU annual total debt is up +37.81% year-on-year

Annual Long Term Debt

$3.36 M
ACIU annual long term debt is $3.36 million

Annual Short Term Debt

$800.10 K
ACIU annual short term debt is $800.10 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$76.20 M
ACIU annual total expenses is $76.20 million

Annual Operating Expenses

$76.20 M
ACIU annual total operating expenses is $76.20 million

Annual Cost Of Goods Sold

-
ACIU annual cost of goods sold value is unknown

Annual SGA

$11.78 M
ACIU annual SGA is $11.78 million

Annual D&A

$2.47 M
ACIU annual depreciation & amortization is $2.47 million

Annual Interest Expense

$196.00 K
ACIU annual interest expense is $196.00 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$67.27 M
ACIU annual cash flow from operations is -$67.27 million

Annual CFO 1-Year Change

+12.79%
ACIU annual cash flow from operations is up +12.79% year-on-year

Annual CFI

$73.11 M
ACIU annual cash flow from investing activities is $73.11 million

Annual CFI 1-Year Change

+193.41%
ACIU annual cash flow from investing activities is up +193.41% year-on-year

Annual CFF

$48.17 M
ACIU annual cash flow from financing activities is $48.17 million

Annual CFF 1-Year Change

+3512.87%
ACIU annual cash flow from financing activities is up +3512.87% year-on-year

Free CashFlow

Annual FCF

-$68.17 M
ACIU annual free cash flow is -$68.17 million

Annual FCF 1-Year Change

+13.09%
ACIU annual free cash flow is up +13.09% year-on-year

CAPEX

Annual CAPEX

$892.00 K
ACIU annual capital expenditures is $892.00 thousand

Annual CAPEX 1-Year Change

-31.34%
ACIU annual capital expenditures is down -31.34% year-on-year

Institutional Ownership

Similar stocks

DRUG logo
Bright Minds Biosciences (DRUG)
ELDN logo
Eledon Pharmaceuticals (ELDN)
CDXS logo
Codexis (CDXS)
Septerna (SEPN)
Neumora Therapeutics (NMRA)
ZYXI logo
Zynex (ZYXI)
ANIK logo
Anika Therapeutics (ANIK)
YMAB logo
Y-mAbs Therapeutics (YMAB)
RZLT logo
Rezolute (RZLT)

FAQ

  • What is the ticker symbol for AC Immune SA?
  • Does AC Immune SA pay dividends?
  • What sector is AC Immune SA in?
  • What industry is AC Immune SA in?
  • What country is AC Immune SA based in?
  • When did AC Immune SA go public?
  • Is AC Immune SA in the S&P 500?
  • Is AC Immune SA in the NASDAQ 100?
  • Is AC Immune SA in the Dow Jones?
  • When was AC Immune SA's last earnings report?
  • When does AC Immune SA report earnings?

What is the ticker symbol for AC Immune SA?

The ticker symbol for AC Immune SA is NASDAQ:ACIU

Does AC Immune SA pay dividends?

No, AC Immune SA does not pay dividends

What sector is AC Immune SA in?

AC Immune SA is in the Healthcare sector

What industry is AC Immune SA in?

AC Immune SA is in the Biotechnology industry

What country is AC Immune SA based in?

AC Immune SA is headquartered in Switzerland

When did AC Immune SA go public?

AC Immune SA's initial public offering (IPO) was on September 23, 2016

Is AC Immune SA in the S&P 500?

No, AC Immune SA is not included in the S&P 500 index

Is AC Immune SA in the NASDAQ 100?

No, AC Immune SA is not included in the NASDAQ 100 index

Is AC Immune SA in the Dow Jones?

No, AC Immune SA is not included in the Dow Jones index

When was AC Immune SA's last earnings report?

AC Immune SA's most recent earnings report was on Oct 24, 2024

When does AC Immune SA report earnings?

The next expected earnings date for AC Immune SA is Mar 13, 2025